GB0015761D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB0015761D0
GB0015761D0 GB0015761A GB0015761A GB0015761D0 GB 0015761 D0 GB0015761 D0 GB 0015761D0 GB 0015761 A GB0015761 A GB 0015761A GB 0015761 A GB0015761 A GB 0015761A GB 0015761 D0 GB0015761 D0 GB 0015761D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0015761A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bristol filed Critical University of Bristol
Priority to GB0015761A priority Critical patent/GB0015761D0/en
Publication of GB0015761D0 publication Critical patent/GB0015761D0/en
Priority to AU2001274344A priority patent/AU2001274344A1/en
Priority to PCT/GB2001/002861 priority patent/WO2002006480A2/en
Ceased legal-status Critical Current

Links

GB0015761A 2000-06-27 2000-06-27 Polypeptide Ceased GB0015761D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0015761A GB0015761D0 (en) 2000-06-27 2000-06-27 Polypeptide
AU2001274344A AU2001274344A1 (en) 2000-06-27 2001-06-27 Tissue inhibitors of matrix metalloproteinases
PCT/GB2001/002861 WO2002006480A2 (en) 2000-06-27 2001-06-27 Tissue inhibitors of matrix metalloproteinases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0015761A GB0015761D0 (en) 2000-06-27 2000-06-27 Polypeptide

Publications (1)

Publication Number Publication Date
GB0015761D0 true GB0015761D0 (en) 2000-08-16

Family

ID=9894527

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0015761A Ceased GB0015761D0 (en) 2000-06-27 2000-06-27 Polypeptide

Country Status (3)

Country Link
AU (1) AU2001274344A1 (en)
GB (1) GB0015761D0 (en)
WO (1) WO2002006480A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10138550A1 (en) * 2001-08-06 2003-02-20 Wolfgang E Berdel Use of tissue inhibitor of metalloprotease-1 and encoding nucleic acid, as immunosuppressant, e.g. for treating multiple sclerosis, rheumatoid arthritis, chronic hepatitis C and asthma
WO2017120461A1 (en) 2016-01-08 2017-07-13 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
US20160208011A1 (en) 2010-01-28 2016-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
US9161968B2 (en) 2011-04-08 2015-10-20 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
MX2016007492A (en) 2013-12-09 2017-03-06 Univ Leland Stanford Junior Methods and compositions for treating aging-associated conditions.
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
JP6921006B2 (en) 2015-06-15 2021-08-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Methods and compositions for treating aging-related symptoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219776T1 (en) * 1989-03-21 2002-07-15 Us Secretary United States Dep MATRIC METALLOPROTEINASE INHIBITOR PEPTIDES
AU3429993A (en) * 1992-01-10 1993-08-03 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
JPH1017492A (en) * 1996-07-02 1998-01-20 Fuji Yakuhin Kogyo Kk Tumor cell proliferation suppressant
DE19850986A1 (en) * 1998-11-05 2000-05-25 Aventis Pharma Gmbh The genetic engineering of cells and their use for the prophylaxis and therapy of diseases

Also Published As

Publication number Publication date
WO2002006480A3 (en) 2004-02-26
AU2001274344A1 (en) 2002-01-30
WO2002006480A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
GB0014870D0 (en) Peptides
AU8441801A (en) Novel polypeptide
GB0029777D0 (en) Peptides
GB0015761D0 (en) Polypeptide
GB0127017D0 (en) New polypeptide
GB0001825D0 (en) Peptides
GB0120704D0 (en) Polypeptide
GB0124559D0 (en) New polypeptide
GB0127028D0 (en) New polypeptide
EP1354947A4 (en) Novel polypeptide
GB0013239D0 (en) Polypeptide
GB0007263D0 (en) Peptides
EP1179592A4 (en) Proteins nectin-3
GB0012199D0 (en) New polypeptide
GB0030293D0 (en) Polypeptide
GB0021524D0 (en) Polypeptide
GB0019861D0 (en) Polypeptide
GB0010170D0 (en) Polypeptide
GB0027166D0 (en) Polypeptide
GB0023444D0 (en) Polypeptide
GB0018307D0 (en) Polypeptides
GB0019859D0 (en) New polypeptide
GB0024445D0 (en) New polypeptide
GB0009060D0 (en) New polypeptide
GB0030501D0 (en) New polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)